Microbot Medical (MBOT) Institutional Ownership $3.13 +0.09 (+2.96%) Closing price 04:00 PM EasternExtended Trading$3.09 -0.04 (-1.41%) As of 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Microbot Medical (NASDAQ:MBOT)CurrentInstitutional OwnershipPercentage16.30%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$858.40KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$67.20K Get MBOT Insider Trade Alerts Want to know when executives and insiders are buying or selling Microbot Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MBOT Institutional Buying and Selling by Quarter Microbot Medical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/12/2025 XTX Topco Ltd17,179$43K0.0%N/A0.047% 8/12/2025 American Century Companies Inc.12,710$32K0.0%N/A0.035% 8/12/2025 DNB Asset Management AS192,786$486K0.0%+67.9%0.530% 8/8/2025 Geode Capital Management LLC395,039$996K0.0%+24.7%1.086% 7/17/2025 Lazari Capital Management Inc.21,255$54K0.0%N/A0.058% 7/17/2025 Beacon Capital Management LLC16,000$40K0.0%+166.7%0.044% 7/14/2025 U.S. Capital Wealth Advisors LLC10,000$25K0.0%N/A0.027% 6/27/2025Goldman Sachs Group Inc.37,744$57K0.0%N/A0.104% 5/16/2025Goldman Sachs Group Inc.37,744$57K0.0%N/A0.109% 5/12/2025 Virtu Financial LLC27,655$42K0.0%N/A0.080% Get the Latest News and Ratings for MBOT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter. 2/13/2025Renaissance Technologies LLC105,658$118K0.0%N/A0.522% 2/12/2025 Geode Capital Management LLC142,659$160K0.0%+7.9%0.705% 1/31/2025AlphaCentric Advisors LLC40,000$45K0.0%-60.0%0.198% 8/9/2024Renaissance Technologies LLC29,295$30K0.0%-64.1%0.183% 8/8/2024 Thoroughbred Financial Services LLC52,250$53K0.0%N/A0.327% 2/13/2024Armistice Capital LLC300,000$492K0.0%N/A2.562% 11/8/2022AlphaCentric Advisors LLC100,000$478K0.5%N/A0.000% 5/12/2022Blueshift Asset Management LLC12,841$81K0.0%N/A0.181% 2/25/2022AlphaCentric Advisors LLC100,000$750K0.2%N/A1.407% 11/9/2021BlackRock Inc.155,013$1.09M0.0%+11.7%2.181% 8/16/2021State Street Corp34,470$274K0.0%N/A0.485% 8/13/2021Renaissance Technologies LLC40,113$318K0.0%N/A0.564% 8/12/2021 Dimensional Fund Advisors LP53,378$424K0.0%N/A0.751% 8/11/2021 Bank of New York Mellon Corp15,610$124K0.0%-15.0%0.220% 5/21/2021Citadel Advisors LLC16,493$140K0.0%N/A0.232% 5/18/2021Millennium Management LLC11,231$96K0.0%N/A0.158% (Data available from 1/1/2016 forward) MBOT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MBOT shares? During the previous two years, 13 institutional investors and hedge funds held shares of Microbot Medical. The most heavily invested institutionals were Geode Capital Management LLC ($996K), Armistice Capital LLC ($492K), DNB Asset Management AS ($486K), Renaissance Technologies LLC ($118K), Goldman Sachs Group Inc. ($57K), Lazari Capital Management Inc. ($54K), and Thoroughbred Financial Services LLC ($53K).Learn more on Microbot Medical's institutional investors. What percentage of Microbot Medical's stock is owned by institutional investors? 16.30% of Microbot Medical's stock is owned by institutional investors. Learn more on MBOT's institutional investor holdings. Which institutional investors have been buying Microbot Medical's stock? Of the 12 institutional investors that purchased Microbot Medical's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($300K), Renaissance Technologies LLC ($105.66K), Geode Capital Management LLC ($88.56K), DNB Asset Management AS ($77.97K), Goldman Sachs Group Inc. ($75.49K), Thoroughbred Financial Services LLC ($52.25K), and Virtu Financial LLC ($27.66K). How much institutional buying is happening at Microbot Medical? Institutional investors have bought a total of 446,473 shares in the last 24 months. This purchase volume represents approximately $858.40K in transactions. Which of Microbot Medical's major shareholders have been selling company stock? The following institutional investors have sold Microbot Medical stock in the last 24 months: AlphaCentric Advisors LLC ($60K). How much institutional selling is happening at Microbot Medical? Institutional investors have sold a total of 60,000 shares in the last 24 months. This volume of shares sold represents approximately $67.20K in transactions. Related Companies Delcath Systems Major Shareholders Butterfly Network Major Shareholders Treace Medical Concepts Major Shareholders RxSight Major Shareholders Sanuwave Health Major Shareholders NeuroPace Major Shareholders Neuronetics Major Shareholders Perspective Therapeutics Major Shareholders ClearPoint Neuro Major Shareholders Outset Medical Major Shareholders This page (NASDAQ:MBOT) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access